[go: up one dir, main page]

WO2020096004A1 - Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus - Google Patents

Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus Download PDF

Info

Publication number
WO2020096004A1
WO2020096004A1 PCT/JP2019/043713 JP2019043713W WO2020096004A1 WO 2020096004 A1 WO2020096004 A1 WO 2020096004A1 JP 2019043713 W JP2019043713 W JP 2019043713W WO 2020096004 A1 WO2020096004 A1 WO 2020096004A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture
medium
cells
cell culture
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2019/043713
Other languages
French (fr)
Japanese (ja)
Inventor
一公 川島
雄毅 羽生
景太 福本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Integriculture Inc
Integriculture Inc
Original Assignee
Integriculture Inc
Integriculture Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CN202510480890.9A priority Critical patent/CN120290455A/en
Priority to US17/292,131 priority patent/US20210395678A1/en
Priority to KR1020247023865A priority patent/KR20240116562A/en
Priority to SG11202104775SA priority patent/SG11202104775SA/en
Priority to EP19883197.6A priority patent/EP3878941A4/en
Priority to CN201980074375.3A priority patent/CN113015789A/en
Application filed by Integriculture Inc, Integriculture Inc filed Critical Integriculture Inc
Priority to JP2020555593A priority patent/JP7488571B2/en
Priority to KR1020217016436A priority patent/KR102686837B1/en
Publication of WO2020096004A1 publication Critical patent/WO2020096004A1/en
Anticipated expiration legal-status Critical
Priority to JP2023207262A priority patent/JP7628338B2/en
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/58Reaction vessels connected in series or in parallel
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/26Conditioning fluids entering or exiting the reaction vessel
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/44Means for regulation, monitoring, measurement or control, e.g. flow regulation of volume or liquid level
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/46Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/02Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00Culture process characterised by the use of hydrostatic pressure, flow or shear forces

Definitions

  • the present invention relates to an animal cell growth promoter, an animal cell culture medium, and an animal cell culture device.
  • a serum medium in which fetal bovine serum or the like is added to the medium as a factor having a function of maintaining cell growth or a serum-free medium in which hormones or growth factors are added in place of serum is generally used. ..
  • Japanese Patent Laid-Open No. 2013-247927 discloses that rice bran extract has a growth promoting action on cultured animal cells.
  • Japanese Patent Laid-Open No. 2011-182736 discloses that the cell growth rate can be increased by culturing animal cells in a medium containing a hydrolyzate of a ⁇ -conglycinin concentrate.
  • JP-A-7-188292 discloses that a glycoprotein contained in the culture supernatant of human-derived fibroblasts promotes the growth of human vascular endothelial cells and hepatocytes.
  • JP-A-5-301893 discloses that a protein contained in a cell culture supernatant obtained by culturing a human-derived glioma cell line has a growth promoting effect on glial cells and fibroblasts.
  • the object of the present invention is to provide a novel animal cell growth promoter, animal cell culture medium and animal cell culture device.
  • One embodiment according to the present invention is an animal cell growth promoter containing, as an active ingredient, the culture supernatant of the embryonic membrane of an avian or reptile egg.
  • the egg may be a chicken egg.
  • the animal cell growth promoter may be a cell growth agent for muscle cells, visceral cells, or nervous cells, or a cell growth agent for liver cells, pancreatic cells, or oviduct cells.
  • Another embodiment of the present invention is a cell culture medium containing the cell growth promoter described in any of the above.
  • Another embodiment according to the present invention is a first culture tank for culturing cells derived from embryonic membrane of an avian or reptile egg, a second culture tank for culturing animal cells for the purpose of proliferation, and A first flow path for flowing the medium from the first culture tank to the second culture tank; a second flow path for flowing the medium from the second culture tank to the first culture tank; The cell culture medium is refluxed in the order of the first flow channel, the second culture tank, and the second flow channel, and the first flow channel and the second flow channel are set according to the state of the animal cells and / or the cell culture medium.
  • An animal cell culture device comprising: a medium flow rate control unit that controls the flow of the cell culture medium in a flow path.
  • a medium introduction path for introducing a fresh cell culture medium into the refluxing cell culture medium, and a medium removal for removing the cell culture medium after culturing from the refluxing cell culture medium The medium flow rate control unit further comprises a passage, and the medium flow control unit introduces the fresh cell culture medium from the medium introduction passage and the medium removal passage according to the state of the animal cell and / or the cell culture medium. The removal of the culture medium for cell culture after the culture may be controlled.
  • FIG. 1 It is a schematic diagram of the cell proliferation apparatus in one embodiment of the present invention.
  • the tissue shown in the figure stomach, skeletal muscle, heart, gallbladder, intestine, brain, bursa of Fabricius and bone
  • 5 is a photograph of observation results showing that cell proliferation is promoted in cells of No. 1 is a graph quantitatively showing the results of FIG. 1 for liver, pancreas, and oviduct-derived cells in one example of the present invention.
  • cells derived from the tissues shown in the figure are a graph showing that cell proliferation is promoted by.
  • Birds or reptiles that are the origin of the eggs that collect the germinal membranes include, but are not limited to, quail, chickens, lizards, snakes, crocodiles, turtles, etc., and are birds or reptile animals that have germinal membranes of eggs. I wish I had it.
  • the embryonic membrane refers to a membrane tissue that is formed outside the embryo body during the development process of birds and reptiles, and has functions such as protection of the embryo, nutrition and respiration, and is not involved in the construction of the body after hatching or birth.
  • the serosa located on the outermost side of the embryo, the amniotic membrane that wraps the embryo body, the allantois that creates the urinary sac, the chorioallantoic membrane (CAM) in which the serosa and allantois are partially adhered, and the yolk.
  • CAM chorioallantoic membrane
  • Examples include the yolk sac that wraps.
  • the culture supernatant of the germinal membrane is a medium in which the germinal membrane is isolated and cultured.
  • the germinal membrane to be cultured may be one kind or a mixture of plural kinds among the above-mentioned membranes such as serosa, amniotic membrane, allantoic membrane, allantoic membrane and yolk sac.
  • the embryonic membrane can be collected from the egg by a known method (for example, see Eiji Ichishima: Chemistry and Biology, 13: 8, p489-497 (1975)).
  • the embryo membrane can be isolated by the following method. First, after fertilized eggs are incubated for a predetermined period under conditions suitable for artificial hatching, the eggshell is split, and (1) the allantoic membrane is obtained by taking out the swollen membrane generated from the ventral side of the posterior part of the digestive tract of the embryo. (2) The amniotic membrane can be obtained by taking out the transparent membranous tissue around the fetus in which blood vessels are not running, and (3) the yolk sac is the membranous tissue surrounding the yolk.
  • the serosa can be obtained by removing the outermost membranous tissue surrounding all the elements in the egg. Further, when the incubation time is extended, the serosa and the allanto partially fuse to form the chorioallantoic membrane. At this time, the chorioallantoic membrane is in contact with the eggshell and can be obtained by taking out the membrane tissue in which blood vessels are running.
  • the optimal incubation period may be determined depending on each animal and the target membrane tissue. For example, in the case of chicken eggs, 4 days to 21 days are preferable, 10 days to 18 days are more preferable, and 13 days to 15 days is more preferred.
  • these embryonic membranes When culturing these embryonic membranes, they may be cultured in a membranous state, but by physically disrupting the membrane or performing enzymatic treatment with a protease (eg, collagenase, elastase, dispase, papain). Alternatively, cells derived from the embryonic membrane may be isolated and cultured.
  • a protease eg, collagenase, elastase, dispase, papain.
  • cells derived from the embryonic membrane may be isolated and cultured.
  • a medium used for general animal cell culture can be used, and examples thereof include, but are not limited to, DMEM and F12.
  • supplements usually added as a medium additive may be added.
  • the conditions used for usual animal cell culture can be used, and typically, a carbonate buffer medium is used for culturing at 5% CO 2, 37 ° C. It is not limited and can be appropriately selected by those skilled in the art.
  • the culture time is not particularly limited, but is preferably 1 to 7 days, more preferably 2 to 6 days. After culturing, the supernatant may be collected and added to the cell culture medium as it is, but a medium obtained by removing solid matters such as cell debris by filtration or centrifugation may be added.
  • the amount of the culture supernatant added to the cell culture medium is not particularly limited as long as it is an effective amount at which the growth effect of the cultured cells is recognized, but the final concentration in the medium is preferably 20% or more, more preferably 35% or more. , 50% or more is more preferable.
  • the type of animal cells to be cultured in the cell culture medium to which this culture supernatant is added is not particularly limited, and muscle cells such as smooth muscle cells, cardiomyocytes and skeletal muscle cells, heart cells, hepatocytes, cells derived from the stomach Examples thereof include visceral cells such as cells derived from intestines, and neural cells such as nerve cells and glial cells.
  • muscle cells such as smooth muscle cells, cardiomyocytes and skeletal muscle cells, heart cells, hepatocytes, cells derived from the stomach
  • visceral cells such as cells derived from intestines
  • neural cells such as nerve cells and glial cells.
  • the animal species from which the cells are derived is not particularly limited, and examples thereof include humans, mice, rats, monkeys and pigs.
  • this culture supernatant obtained by culturing cells derived from embryonic membrane to the animal cell culture medium, it is possible to promote the growth of the cultivated animal cells. Therefore, this culture supernatant can be used as an animal cell growth promoter.
  • the cell expansion device of the present invention comprises a first culture tank for culturing cells derived from embryonic membrane of an avian or reptile egg, a second culture tank for culturing animal cells for the purpose of proliferation, and a first culture.
  • the cell culture medium is refluxed in the order of the channel, the second culture tank, and the second channel, and the first channel and the second channel are flown according to the state of the animal cells and / or the cell culture medium.
  • a medium flow rate control unit that controls the flow of the cell culture medium.
  • the first culture tank culture according to the method for culturing cells derived from embryonic membrane, which is performed when preparing the animal cell growth promoting agent as described above, is performed.
  • the second culture tank culturing according to the culturing method of culturing animal cells in the medium to which the animal cell growth promoter is added as described above is performed.
  • the first culture tank and the second culture tank are fluidly connected by the first flow path and the second flow path.
  • the first culture tank 11 and the second culture tank 12 may be directly connected by the first flow channel 21 and the second flow channel 22.
  • one or a plurality of other culture tanks may be provided, and the other culture tank and the first culture tank 11 or Various configurations can be considered for connection with the two culture tanks 12.
  • a third culture tank 13 is provided in the middle of the first flow path 21, and the flow path extends from the first culture tank 11 through the third culture tank 13 to the second culture tank 13. It may be connected to the tank 12.
  • FIG. 1 (B) a third culture tank 13 is provided in the middle of the first flow path 21, and the flow path extends from the first culture tank 11 through the third culture tank 13 to the second culture tank 13. It may be connected to the tank 12.
  • FIG. 1 (B) a third culture tank 13 is provided in the middle of the first flow path 21, and the flow path extends from the first culture tank 11 through the third culture tank 13 to the second culture tank 13.
  • a third culture tank 13 is provided independently of the second culture tank 12, and the flow channels are the first flow channel 21 and the second flow channel 22. Separately, a third channel 31 and a fourth channel 32 that fluidly connect the first culture tank 11 and the third culture tank 13 may be provided.
  • the cells are cultured in the first culture tank 11 or the second culture tank 12. Can affect or influence their culture.
  • the influence of the culture in the first culture tank 11 and the culture in the culture tanks other than the second culture tank 12 from the culture in the first culture tank and the culture in the second culture tank There are various possible effects on the culture in the first culture tank and the culture in the second culture tank.
  • cell growth, cell differentiation, tissue morphogenesis, pH adjustment of the medium Examples include prevention of bacterial contamination.
  • the third culture tank 13 cells that are different from the cells in the second culture tank 12 and that can grow in a medium in which cells derived from germinal membrane are cultivated.
  • the cells can be simultaneously grown in the second culture tank 12 and the third culture tank 13.
  • by culturing cells derived from the embryonic membrane different from the first culturing tank 11 in the third culturing tank 13 it is possible to further promote the growth of the cells cultivated in the second culturing tank 12. it can.
  • the cells cultured in the third culture tank 13 are cells capable of growing in a medium in which cells derived from germinal membranes are cultured and secreting factors that grow the cells cultured in the second culture tank 12. Good.
  • the tanks may be connected to each other by a pipe, and the pipe may form a flow path.
  • a valve may be installed in these pipes.
  • the medium flow rate control unit monitors the state of the cells being cultured and / or the medium for cell culture, and according to the state, the flow of the medium for cell culture in each flow path through this valve (for example, flow velocity, flow rate, etc.). ) May be controlled.
  • the structure of the valve is not particularly limited as long as it is a well-known structure such as a flange type or a screw type, and the method for adjusting the valve is not particularly limited, and a known structure such as an air-driven type, an electromagnetic type, an electric type, or a hydraulic type is used. Any adjustment method may be used. Further, in order to prevent the backflow of the cell culture medium in the tube, the tube may be provided with a check valve.
  • Examples of the state of the cells and / or cell culture medium monitored by the medium flow rate control unit include, but are not limited to, the state of cell proliferation, the state of cell differentiation, and the pH of the medium.
  • the state of cell proliferation can be determined by, for example, counting the number of cells per unit area or measuring the ratio of the area occupied by cells to the bottom area of the plate.
  • the state of cell differentiation can be determined by measuring fluorescence by, for example, introducing into the cells a marker gene that expresses upon differentiation and emits fluorescence.
  • the pH of the medium for example, the pH may be directly measured, or a pigment that changes depending on the pH may be added to the medium and the color may be used for the determination.
  • a fertilized egg of a chicken is incubated at 37 ° C, and 14 days later, the eggshell is broken, and the membrane tissue in contact with the eggshell and in which blood vessels are running is taken out as chorioallantoic membrane, while the membrane surrounding the yolk is taken out.
  • the tissue was taken out as an yolk sac and each of these membrane tissues was immersed in HBSS (Hank's Balanced Salt Solution). These membrane tissues were physically finely cut with tweezers or the like, and then centrifuged to remove the supernatant.
  • a collagenase solution (200 IU / mL) was added to each isolated membrane tissue, and the mixture was kept at 37 ° C for 1 hour and then centrifuged again to remove the supernatant.
  • HBSS was added to each collagenase-treated membrane tissue, filtered through a 40 ⁇ m filter, and the resulting filtrate was centrifuged to remove the supernatant to collect chorioallantoic membrane-derived cells or yolk sac-derived cells.
  • the chorioallantoic membrane-derived cells or yolk sac-derived cells are preserved, the cells are suspended in a cell freezing solution (10% DMSO solution) and frozen by gradually cooling to -80 ° C, and then -80 ° C. Saved in.
  • the chorioallantoic membrane-derived cell or yolk sac-derived cell obtained in (1) contains 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (PS) solution
  • FBS fetal bovine serum
  • PS penicillin-streptomycin
  • the cells were seeded in a cell culture dish (diameter 10 cm) at a concentration of 4 ⁇ 10 6 cells / dish, and the amount was 2 to 3 at 37 ° C. and 5% CO 2 environment. Cultured for 4 days.
  • fertilized chicken eggs were incubated at 37 ° C, and 14 days later, the eggshells were broken and the chicken embryos were taken out.
  • a stomach, skeletal muscle, heart, gall bladder, intestine, brain, bursa of Fabricius and bone were isolated from the embryonic day 14 chicken, and each was immersed in an HBSS solution. Then, cells derived from each tissue were isolated by the same method as in (1).
  • the culture solution of cells derived from each tissue was removed from the dish, and PBS was added to wash the cells. After removing the PBS, a trypsin-EDTA solution was added and the cells were detached by incubating at 37 ° C. for 1 to 2 minutes, and then FBS / PS-containing DMEM was added to stop the reaction. All the solution containing the detached cells was collected and centrifuged to obtain cells. Further, FBS.PS was added to the cells to suspend the cells, and 20 ⁇ L of the cell suspension was mixed with 20 ⁇ L of trypan blue solution. The number of live cells not stained with trypan blue in this cell suspension was counted under a microscope using a hemocytometer.
  • FIG. 3 shows the average number of cells and the standard error in the case of using the chorioallantoic membrane culture supernatant for cells derived from the liver, pancreas, and oviduct in three petri dishes.
  • the addition of chorioallantoic membrane culture supernatant resulted in approximately 2.5 to 4 times more cells than the case without addition of chorioallantoic membrane culture supernatant.
  • the addition of chorioallantoic membrane culture supernatant resulted in approximately 2.5 to 4 times more cells than the case without addition of chorioallantoic membrane culture supernatant. was growing.
  • the present invention has made it possible to provide a novel animal cell growth promoter, an animal cell culture medium, and an animal cell culture device.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

[Problem] The purpose of the present invention is to provide a novel animal cell growth promoter. Specifically, a culture supernatant of an embryonic membrane of a bird or reptile egg is used as an animal cell growth promoter. For example, the growth of animal cells can be promoted by the addition, to a culture medium for animal cell culture, of a cell growth agent that contains as an active ingredient the culture supernatant of an embryonic membrane of a bird or reptile egg.

Description

動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置Animal cell growth promoter, animal cell culture medium and animal cell culture device

 本発明は、動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置に関する。 The present invention relates to an animal cell growth promoter, an animal cell culture medium, and an animal cell culture device.

 動物細胞の培養においては、一般に細胞増殖を維持する機能を有する因子として培地にウシ胎児血清等を添加した血清培地や血清の代わりにホルモンや増殖因子などを添加した無血清培地が用いられている。 In culturing animal cells, a serum medium in which fetal bovine serum or the like is added to the medium as a factor having a function of maintaining cell growth or a serum-free medium in which hormones or growth factors are added in place of serum is generally used. ..

 それらの因子以外に、特開2013-247927号公報には、米糠抽出物が培養動物細胞に対して増殖促進作用を有することが開示されている。また、特開2011-182736号公報には、β-コングリシニン濃縮物の加水分解物を添加した培地で動物細胞を培養すると細胞増殖率を高めることができることが開示されている。さらに、特開平7-188292号公報には、ヒト由来の線維芽細胞の培養上清に含まれる糖蛋白質がヒト血管内皮細胞及び肝実質細胞の増殖を促進することが開示されている。さらに、特開平5-301893号公報には、ヒト由来グリオーマ細胞株を培養した細胞培養上清に含まれる蛋白質がグリア細胞や線維芽細胞に対する増殖促進効果を有することが開示されている。 In addition to these factors, Japanese Patent Laid-Open No. 2013-247927 discloses that rice bran extract has a growth promoting action on cultured animal cells. Further, Japanese Patent Laid-Open No. 2011-182736 discloses that the cell growth rate can be increased by culturing animal cells in a medium containing a hydrolyzate of a β-conglycinin concentrate. Further, JP-A-7-188292 discloses that a glycoprotein contained in the culture supernatant of human-derived fibroblasts promotes the growth of human vascular endothelial cells and hepatocytes. Further, JP-A-5-301893 discloses that a protein contained in a cell culture supernatant obtained by culturing a human-derived glioma cell line has a growth promoting effect on glial cells and fibroblasts.

 本発明は、新規な動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置を提供することを目的とする。 The object of the present invention is to provide a novel animal cell growth promoter, animal cell culture medium and animal cell culture device.

 本発明にかかる一実施態様は、鳥類または爬虫類の卵の胚膜の培養上清を有効成分として含有する動物細胞増殖促進剤である。前記卵がニワトリ卵であってもよい。前記動物細胞増殖促進剤が、筋肉系細胞、内臓系細胞、または神経系細胞に対する細胞増殖剤であってもよく、肝臓細胞、膵臓細胞、輸卵管細胞に対する細胞増殖剤であってもよい。 One embodiment according to the present invention is an animal cell growth promoter containing, as an active ingredient, the culture supernatant of the embryonic membrane of an avian or reptile egg. The egg may be a chicken egg. The animal cell growth promoter may be a cell growth agent for muscle cells, visceral cells, or nervous cells, or a cell growth agent for liver cells, pancreatic cells, or oviduct cells.

 本発明にかかる他の一実施態様は、上記いずれかに記載の細胞増殖促進剤を含有する細胞培養用培地である。 Another embodiment of the present invention is a cell culture medium containing the cell growth promoter described in any of the above.

 本発明にかかる他の一実施態様は、鳥類または爬虫類の卵の胚膜由来の細胞を培養する第1の培養槽と、増殖を目的とする動物細胞を培養する第2の培養槽と、第1の培養槽から第2の培養槽へ培地を流す第1の流路と、第2の培養槽から第1の培養槽へ培地を流す第2の流路と、第1の培養槽、第1の流路、第2の培養槽、第2の流路の順に細胞培養用培地を還流させ、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、第1の流路及び第2の流路における前記細胞培養用培地の流れを制御する培地流量制御部と、を備える動物細胞培養装置である。また、前記還流する前記細胞培養用培地に新鮮な細胞培養用培地を導入するための培地導入路と、前記還流する前記細胞培養用培地から培養後の細胞培養用培地を除去するための培地除去路と、をさらに有し、前記培地流量制御部は、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、前記培地導入路からの前記新鮮な細胞培養用培地の導入及び前記培地除去路からの前記培養後の細胞培養用培地の除去を制御するものであってもよい。 Another embodiment according to the present invention is a first culture tank for culturing cells derived from embryonic membrane of an avian or reptile egg, a second culture tank for culturing animal cells for the purpose of proliferation, and A first flow path for flowing the medium from the first culture tank to the second culture tank; a second flow path for flowing the medium from the second culture tank to the first culture tank; The cell culture medium is refluxed in the order of the first flow channel, the second culture tank, and the second flow channel, and the first flow channel and the second flow channel are set according to the state of the animal cells and / or the cell culture medium. An animal cell culture device comprising: a medium flow rate control unit that controls the flow of the cell culture medium in a flow path. In addition, a medium introduction path for introducing a fresh cell culture medium into the refluxing cell culture medium, and a medium removal for removing the cell culture medium after culturing from the refluxing cell culture medium The medium flow rate control unit further comprises a passage, and the medium flow control unit introduces the fresh cell culture medium from the medium introduction passage and the medium removal passage according to the state of the animal cell and / or the cell culture medium. The removal of the culture medium for cell culture after the culture may be controlled.

==関連文献とのクロスリファレンス==
 本出願は、2018年11月8日付で出願した日本国特許出願2018-210910に基づく優先権を主張するものであり、当該基礎出願を引用することにより、本明細書に含めるものとする。
== Cross reference with related documents ==
This application claims priority based on Japanese Patent Application 2018-210910 filed on Nov. 8, 2018, and is incorporated herein by reference to the basic application.

本発明の一実施形態における細胞増殖装置の模式図である。It is a schematic diagram of the cell proliferation apparatus in one embodiment of the present invention. 本発明の一実施例において、ニワトリ卵漿尿膜の培養上清を培地に添加した場合に、図に示した組織(胃、骨格筋、心臓、胆嚢、腸、脳、ファブリキウス嚢及び骨)由来の細胞で細胞増殖が促進されることを示す観察結果の写真である。In one embodiment of the present invention, when the culture supernatant of chicken chorioallantoic membrane is added to the medium, the tissue shown in the figure (stomach, skeletal muscle, heart, gallbladder, intestine, brain, bursa of Fabricius and bone) is derived. 5 is a photograph of observation results showing that cell proliferation is promoted in cells of No. 本発明の一実施例において、肝臓、膵臓、および輸卵管由来の細胞について、図1の結果を定量的に示したグラフである。1 is a graph quantitatively showing the results of FIG. 1 for liver, pancreas, and oviduct-derived cells in one example of the present invention. 本発明の一実施例において、ニワトリ卵卵黄嚢の培養上清を培地に添加した場合に、図に示した組織(胃、筋肉、心臓、肝臓、腸、脳、ファブリキウス嚢及び骨)由来の細胞で細胞増殖が促進されることを示すグラフである。In one embodiment of the present invention, cells derived from the tissues shown in the figure (stomach, muscle, heart, liver, intestine, brain, Fabricius bursa and bone), when the culture supernatant of chicken egg yolk sac is added to the medium 3 is a graph showing that cell proliferation is promoted by.

 本発明の目的、特徴、利点、およびそのアイデアは、本明細書の記載により、当業者には明らかであり、本明細書の記載から、当業者であれば、容易に本発明を再現できる。以下に記載された発明の実施の形態および具体的な実施例などは、本発明の好ましい実施態様を示すものであり、例示または説明のために示されているのであって、本発明をそれらに限定するものではない。本明細書で開示されている本発明の意図並びに範囲内で、本明細書の記載に基づき、様々な改変並びに修飾ができることは、当業者にとって明らかである。 The objects, features, advantages, and ideas of the present invention will be apparent to those skilled in the art from the description of the present specification, and those skilled in the art can easily reproduce the present invention from the description of the present specification. The embodiments and specific examples of the invention described below show preferred embodiments of the present invention, and are provided for the purpose of illustration or explanation, and the present invention is not limited thereto. It is not limited. It will be apparent to those skilled in the art that various alterations and modifications can be made based on the description of the present specification within the intention and scope of the present invention disclosed in the present specification.

==動物細胞増殖促進剤==
 本開示の動物細胞増殖促進剤は、鳥類または爬虫類の卵の胚膜の培養上清を有効成分として含有する。
== Animal cell growth promoter ==
The animal cell growth promoter of the present disclosure contains a culture supernatant of an embryonic membrane of an egg of a bird or a reptile as an active ingredient.

 胚膜を採取する卵の由来である鳥類または爬虫類は、ウズラ、ニワトリ、トカゲ、ヘビ、ワニ、カメなどが例示できるが、これらに限定されず、卵の胚膜を有する鳥類または爬虫類の動物であればよい。 Birds or reptiles that are the origin of the eggs that collect the germinal membranes include, but are not limited to, quail, chickens, lizards, snakes, crocodiles, turtles, etc., and are birds or reptile animals that have germinal membranes of eggs. I wish I had it.

 ここで胚膜とは、鳥類・爬虫類の発生過程において、胚体外に形成され、胚の保護・栄養・呼吸などの機能を果し、孵化または出生後の体の構築には加わらない膜組織を意味し、例えば、胚の最外側に位置する漿膜、胚体を包む羊膜、尿嚢をつくる尿膜、漿膜と尿膜とが部分的に癒着した漿尿膜(chorioallantoic membrane: CAM)、卵黄を包む卵黄嚢などが挙げられる。 Here, the embryonic membrane refers to a membrane tissue that is formed outside the embryo body during the development process of birds and reptiles, and has functions such as protection of the embryo, nutrition and respiration, and is not involved in the construction of the body after hatching or birth. Meaning, for example, the serosa located on the outermost side of the embryo, the amniotic membrane that wraps the embryo body, the allantois that creates the urinary sac, the chorioallantoic membrane (CAM) in which the serosa and allantois are partially adhered, and the yolk. Examples include the yolk sac that wraps.

 胚膜の培養上清とは、胚膜を単離して培養した培地のことである。培養する胚膜は、上述した漿膜、羊膜、尿膜、尿漿膜、卵黄嚢などの膜のうち、一種類を培養しても、複数種類を混合して培養してもよい。 The culture supernatant of the germinal membrane is a medium in which the germinal membrane is isolated and cultured. The germinal membrane to be cultured may be one kind or a mixture of plural kinds among the above-mentioned membranes such as serosa, amniotic membrane, allantoic membrane, allantoic membrane and yolk sac.

 胚膜は、公知の方法で卵から採取することができる(例えば、一島英治:化学と生物,13巻8号,p489-497(1975)などを参照のこと)。例えば、具体的には、以下のような方法で胚膜を単離できる。まず、有精卵を所定期間人工孵化に適した条件でインキュベートした後、卵殻を割り、(1)尿膜は、胚の消化管後部の腹側から生じている膨らんだ膜を取り出すことで得ることができ、(2)羊膜は、胎児の周囲に存在する血管の走行していない透明の膜組織を取り出すことで得ることができ、(3)卵黄嚢は、卵黄を包んでいる膜組織を取り出すことで得ることができ、(4)漿膜は、卵内のすべての要素を囲んだもっとも外側にある膜組織を取り出すことで得ることができる。さらに、インキュベートする時間を長くすると、漿膜と尿膜は部分的に融合し、漿尿膜となる。この時期に、漿尿膜は、卵殻と接していて、血管が走行している膜組織を取り出すことで得ることができる。インキュベートする期間は、各動物によって、また目的の膜組織によって、最適期間を適宜決めればよく、例えばニワトリ卵の場合、4日~21日間が好ましく、10日~18日間がより好ましく、13日~15日間がさらに好ましい。これら胚膜を培養する際、膜状のまま培養してもよいが、物理的に膜を破砕したり、プロテアーゼ(例えば、コラゲナーゼ、エラスターゼ、ディスパーゼ、パパインなど)で酵素処理を行ったりすることにより、胚膜から胚膜由来の細胞を単離して培養してもよい。 The embryonic membrane can be collected from the egg by a known method (for example, see Eiji Ichishima: Chemistry and Biology, 13: 8, p489-497 (1975)). For example, specifically, the embryo membrane can be isolated by the following method. First, after fertilized eggs are incubated for a predetermined period under conditions suitable for artificial hatching, the eggshell is split, and (1) the allantoic membrane is obtained by taking out the swollen membrane generated from the ventral side of the posterior part of the digestive tract of the embryo. (2) The amniotic membrane can be obtained by taking out the transparent membranous tissue around the fetus in which blood vessels are not running, and (3) the yolk sac is the membranous tissue surrounding the yolk. (4) The serosa can be obtained by removing the outermost membranous tissue surrounding all the elements in the egg. Further, when the incubation time is extended, the serosa and the allanto partially fuse to form the chorioallantoic membrane. At this time, the chorioallantoic membrane is in contact with the eggshell and can be obtained by taking out the membrane tissue in which blood vessels are running. The optimal incubation period may be determined depending on each animal and the target membrane tissue. For example, in the case of chicken eggs, 4 days to 21 days are preferable, 10 days to 18 days are more preferable, and 13 days to 15 days is more preferred. When culturing these embryonic membranes, they may be cultured in a membranous state, but by physically disrupting the membrane or performing enzymatic treatment with a protease (eg, collagenase, elastase, dispase, papain). Alternatively, cells derived from the embryonic membrane may be isolated and cultured.

 胚膜の培養には、一般的な動物細胞培養に利用する培地を用いることができ、例えば、DMEM、F12などが例示できるが、これらに限定されない。この培地には、培地添加剤として通常配合されているサプリメントを添加してもよい。培養条件も、通常の動物細胞培養に用いられる条件を使用することができ、典型的には、炭酸バッファー系の培地を用いて、5%CO2、37℃で培養するが、培養条件はこれに限定されず、当業者が適宜選択することができる。培養時間は特に限定されないが、1~7日間が好ましく、2~6日間がより好ましい。培養後は、上清を回収し、そのまま細胞培養用培地に添加してもよいが、フィルトレーションや遠心分離などで、細胞残渣などの固形物を除去して得られる培地を添加してもよい。細胞培養用培地への培養上清の添加量は、培養細胞の増殖効果が認められる有効量であれば特に制限されないが、培地中の最終濃度は20%以上が好ましく、35%以上がより好ましく、50%以上がさらに好ましい。 For culturing the embryonic membrane, a medium used for general animal cell culture can be used, and examples thereof include, but are not limited to, DMEM and F12. To this medium, supplements usually added as a medium additive may be added. Regarding the culture conditions, the conditions used for usual animal cell culture can be used, and typically, a carbonate buffer medium is used for culturing at 5% CO 2, 37 ° C. It is not limited and can be appropriately selected by those skilled in the art. The culture time is not particularly limited, but is preferably 1 to 7 days, more preferably 2 to 6 days. After culturing, the supernatant may be collected and added to the cell culture medium as it is, but a medium obtained by removing solid matters such as cell debris by filtration or centrifugation may be added. Good. The amount of the culture supernatant added to the cell culture medium is not particularly limited as long as it is an effective amount at which the growth effect of the cultured cells is recognized, but the final concentration in the medium is preferably 20% or more, more preferably 35% or more. , 50% or more is more preferable.

 この培養上清を添加した細胞培養用培地で培養する動物細胞の種類は特に限定されず、平滑筋細胞、心筋細胞、骨格筋細胞などの筋肉系細胞、心臓細胞、肝細胞、胃由来の細胞、腸由来の細胞などの内臓系細胞、または神経細胞やグリア細胞などの神経系細胞が例示できる。細胞が由来する動物種も特に限定されず、ヒト、マウス、ラット、サル、ブタなどが例示できる。 The type of animal cells to be cultured in the cell culture medium to which this culture supernatant is added is not particularly limited, and muscle cells such as smooth muscle cells, cardiomyocytes and skeletal muscle cells, heart cells, hepatocytes, cells derived from the stomach Examples thereof include visceral cells such as cells derived from intestines, and neural cells such as nerve cells and glial cells. The animal species from which the cells are derived is not particularly limited, and examples thereof include humans, mice, rats, monkeys and pigs.

 このように、胚膜由来の細胞を培養して得られた培養上清を動物細胞培養用培地に添加することにより、培養している動物細胞の増殖を促進させることができる。従って、この培養上清を動物細胞増殖促進剤として用いることができる。 In this way, by adding the culture supernatant obtained by culturing cells derived from embryonic membrane to the animal cell culture medium, it is possible to promote the growth of the cultivated animal cells. Therefore, this culture supernatant can be used as an animal cell growth promoter.

 なお、胚膜由来の細胞の培養上清を動物細胞増殖促進剤として用いる場合、同時に他の細胞増殖因子を用いても構わない。 When using the culture supernatant of cells derived from embryonic membrane as an animal cell growth promoter, other cell growth factors may be used at the same time.

==細胞増殖装置==
 本発明の細胞増殖装置は、鳥類または爬虫類の卵の胚膜由来の細胞を培養する第1の培養槽と、増殖を目的とする動物細胞を培養する第2の培養槽と、第1の培養槽から第2の培養槽へ培地を流す第1の流路と、第2の培養槽から第1の培養槽へ培地を流す第2の流路と、第1の培養槽、第1の流路、第2の培養槽、第2の流路の順に細胞培養用培地を還流させ、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、第1の流路及び第2の流路における前記細胞培養用培地の流れを制御する培地流量制御部と、を備える。
== Cell proliferation device ==
The cell expansion device of the present invention comprises a first culture tank for culturing cells derived from embryonic membrane of an avian or reptile egg, a second culture tank for culturing animal cells for the purpose of proliferation, and a first culture. A first channel for flowing the medium from the tank to the second culture tank, a second channel for flowing the medium from the second culture tank to the first culture tank, a first culture tank, and a first flow The cell culture medium is refluxed in the order of the channel, the second culture tank, and the second channel, and the first channel and the second channel are flown according to the state of the animal cells and / or the cell culture medium. And a medium flow rate control unit that controls the flow of the cell culture medium.

 第1の培養槽では、上述したような、動物細胞増殖促進剤を調製する際に行う胚膜由来の細胞の培養方法に準じた培養を行う。第2の培養槽では、上述したような、動物細胞増殖促進剤を添加した培地で動物細胞を培養する培養方法に準じた培養を行う。 In the first culture tank, culture according to the method for culturing cells derived from embryonic membrane, which is performed when preparing the animal cell growth promoting agent as described above, is performed. In the second culture tank, culturing according to the culturing method of culturing animal cells in the medium to which the animal cell growth promoter is added as described above is performed.

 第1の培養槽と第2の培養槽は、第1の流路と第2の流路とで流体接続されている。例えば、図1(A)のように、第1の培養槽11と第2の培養槽12が第1の流路21と第2の流路22とで直接接続されていてもよい。第1の培養槽11と第2の培養槽12が流体接続されている限り、1つあるいは複数の他の培養槽を設けてもよく、他の培養槽と、第1の培養槽11または第2の培養槽12との接続も様々な構成が考えられる。例えば、図1(B)のように、第1の流路21の途中に第3の培養槽13を設け、流路が第1の培養槽11から第3の培養槽13を通じて第2の培養槽12に接続されていてもよい。あるいは、図1(C)のように、第2の培養槽12とは独立に、第3の培養槽13を設け、流路も、第1の流路21と第2の流路22とは別に、第1の培養槽11と第3の培養槽13を流体接続する第3の流路31と第4の流路32を設けてもよい。(B)や(C)の場合、第3の培養槽13で培養する細胞を適当に選択することによって、その細胞が第1の培養槽11での培養や第2の培養槽12での培養から影響を受けたり、それらの培養に影響を及ぼしたりすることができる。 The first culture tank and the second culture tank are fluidly connected by the first flow path and the second flow path. For example, as shown in FIG. 1A, the first culture tank 11 and the second culture tank 12 may be directly connected by the first flow channel 21 and the second flow channel 22. As long as the first culture tank 11 and the second culture tank 12 are fluidly connected, one or a plurality of other culture tanks may be provided, and the other culture tank and the first culture tank 11 or Various configurations can be considered for connection with the two culture tanks 12. For example, as shown in FIG. 1 (B), a third culture tank 13 is provided in the middle of the first flow path 21, and the flow path extends from the first culture tank 11 through the third culture tank 13 to the second culture tank 13. It may be connected to the tank 12. Alternatively, as shown in FIG. 1 (C), a third culture tank 13 is provided independently of the second culture tank 12, and the flow channels are the first flow channel 21 and the second flow channel 22. Separately, a third channel 31 and a fourth channel 32 that fluidly connect the first culture tank 11 and the third culture tank 13 may be provided. In the case of (B) and (C), by appropriately selecting the cells to be cultured in the third culture tank 13, the cells are cultured in the first culture tank 11 or the second culture tank 12. Can affect or influence their culture.

 ここで、第1の培養槽11での培養や第2の培養槽12以外の培養槽での培養が、第1の培養槽での培養や第2の培養槽での培養から受ける影響や、第1の培養槽での培養や第2の培養槽での培養に与える影響は様々なものが考えられ、例えば、細胞の増殖、細胞の分化、組織の形態形成、培地のpH調製、培地への細菌混入予防などが例示できる。 Here, the influence of the culture in the first culture tank 11 and the culture in the culture tanks other than the second culture tank 12 from the culture in the first culture tank and the culture in the second culture tank, There are various possible effects on the culture in the first culture tank and the culture in the second culture tank. For example, cell growth, cell differentiation, tissue morphogenesis, pH adjustment of the medium, Examples include prevention of bacterial contamination.

 例えば、具体的には、第3の培養槽13に、第2の培養槽12とは異なる細胞であって、胚膜由来の細胞を培養した培地で増殖できる細胞を入れておくことで、第2の培養槽12と第3の培養槽13で、同時に細胞を増殖させることができる。あるいは、第3の培養槽13で、第1の培養槽11とは異なる胚膜由来の細胞を培養することによって、第2の培養槽12で培養している細胞の増殖をさらに促進させることができる。あるいは、第3の培養槽13で培養する細胞が、胚膜由来の細胞を培養した培地で増殖でき、かつ第2の培養槽12で培養する細胞を増殖させる因子を分泌する細胞であってもよい。 For example, specifically, by putting in the third culture tank 13 cells that are different from the cells in the second culture tank 12 and that can grow in a medium in which cells derived from germinal membrane are cultivated, The cells can be simultaneously grown in the second culture tank 12 and the third culture tank 13. Alternatively, by culturing cells derived from the embryonic membrane different from the first culturing tank 11 in the third culturing tank 13, it is possible to further promote the growth of the cells cultivated in the second culturing tank 12. it can. Alternatively, even if the cells cultured in the third culture tank 13 are cells capable of growing in a medium in which cells derived from germinal membranes are cultured and secreting factors that grow the cells cultured in the second culture tank 12. Good.

 槽と槽の間は管で接続され、その管が流路を形成してもよい。また、これらの管には、弁が設置されていてもよい。培地流量制御部が、培養している細胞及び/又は細胞培養用培地の状態をモニターし、その状態に従い、この弁を介して各流路における細胞培養用培地の流れ(例えば、流速、流量など)を制御してもよい。 The tanks may be connected to each other by a pipe, and the pipe may form a flow path. A valve may be installed in these pipes. The medium flow rate control unit monitors the state of the cells being cultured and / or the medium for cell culture, and according to the state, the flow of the medium for cell culture in each flow path through this valve (for example, flow velocity, flow rate, etc.). ) May be controlled.

 弁の構造は特に限定されず、フランジ形、ねじ込み形などの公知の構造であればよく、弁の調整方法も特に限定されず、空気駆動式、電磁式、電動式、油圧式などの公知の調整方法であればよい。また、細胞培養用培地の管内での逆流を防ぐため、管に逆止弁を備えていてもよい。 The structure of the valve is not particularly limited as long as it is a well-known structure such as a flange type or a screw type, and the method for adjusting the valve is not particularly limited, and a known structure such as an air-driven type, an electromagnetic type, an electric type, or a hydraulic type is used. Any adjustment method may be used. Further, in order to prevent the backflow of the cell culture medium in the tube, the tube may be provided with a check valve.

 培地流量制御部がモニターする細胞及び/又は細胞培養用培地の状態とは、例えば、細胞の増殖の様子や、細胞の分化の様子、培地のpHなどが例示できるが、これらに限定されない。細胞の増殖の様子は、例えば、単位面積当たりの細胞数を数えたり、プレートの底面積に対する細胞の占める面積の割合などを測ったりすることで判断できる。細胞の分化の様子は、例えば、分化すると発現して蛍光発光するマーカー遺伝子を細胞に導入しておくことによって、蛍光を測定することで判断できる。培地のpHは、例えば、直接pHを測定してもよく、あるいはpHによって変化する色素を培地に添加しておき、その色で判断してもよい。 Examples of the state of the cells and / or cell culture medium monitored by the medium flow rate control unit include, but are not limited to, the state of cell proliferation, the state of cell differentiation, and the pH of the medium. The state of cell proliferation can be determined by, for example, counting the number of cells per unit area or measuring the ratio of the area occupied by cells to the bottom area of the plate. The state of cell differentiation can be determined by measuring fluorescence by, for example, introducing into the cells a marker gene that expresses upon differentiation and emits fluorescence. Regarding the pH of the medium, for example, the pH may be directly measured, or a pigment that changes depending on the pH may be added to the medium and the color may be used for the determination.

(1)漿尿膜又は卵黄嚢の単離方法
 試験に用いる漿尿膜又は卵黄嚢は、以下の方法によってそれぞれ単離した。
(1) Isolation method of chorioallantoic membrane or yolk sac The chorioallantoic membrane or yolk sac used in the test was isolated by the following method, respectively.

 ニワトリの有精卵を37℃でインキュベートし、14日後に卵殻を割って、卵殻と接していて、血管が走行している膜組織を漿尿膜として取り出すとともに、一方で卵黄を包んでいる膜組織を卵黄嚢として取り出し、これらの膜組織をHBSS(Hank’s Balanced Salt Solution )中にそれぞれ浸漬した。これらの膜組織をピンセットなどで物理的に細かく裁断した後、遠心分離を行い、上清を除去した。 A fertilized egg of a chicken is incubated at 37 ° C, and 14 days later, the eggshell is broken, and the membrane tissue in contact with the eggshell and in which blood vessels are running is taken out as chorioallantoic membrane, while the membrane surrounding the yolk is taken out. The tissue was taken out as an yolk sac and each of these membrane tissues was immersed in HBSS (Hank's Balanced Salt Solution). These membrane tissues were physically finely cut with tweezers or the like, and then centrifuged to remove the supernatant.

 単離した各膜組織に、コラゲナーゼ溶液(200IU/mL)を加えて37℃で1時間保持した後、再度遠心分離を行い、その上清を除去した。このコラゲナーゼ処理した各膜組織にHBSSを加え、40μmのフィルターでろ過し、得られた濾液を遠心分離して上清を除去することにより漿尿膜由来細胞又は卵黄嚢由来細胞を回収した。なお、漿尿膜由来細胞又は卵黄嚢由来細胞を保存する場合には、これを細胞凍結液(10%DMSO溶液)に懸濁し、-80℃まで徐々に冷却することにより凍結し、-80℃で保存した。 A collagenase solution (200 IU / mL) was added to each isolated membrane tissue, and the mixture was kept at 37 ° C for 1 hour and then centrifuged again to remove the supernatant. HBSS was added to each collagenase-treated membrane tissue, filtered through a 40 μm filter, and the resulting filtrate was centrifuged to remove the supernatant to collect chorioallantoic membrane-derived cells or yolk sac-derived cells. When the chorioallantoic membrane-derived cells or yolk sac-derived cells are preserved, the cells are suspended in a cell freezing solution (10% DMSO solution) and frozen by gradually cooling to -80 ° C, and then -80 ° C. Saved in.

(2)漿尿膜又は卵黄嚢の培養方法
 (1)で得られた漿尿膜由来細胞又は卵黄嚢由来細胞を10%ウシ胎児血清(FBS)および1%ペニシリン・ストレプトマイシン(PS)溶液を含有したDMEM(以下、FBS・PS含有DMEMと称する)に加え、4×10cells/dishの濃度で細胞培養用ディッシュ(直径10cm)に播種し、37℃、5%CO環境下で2~4日間培養した。
(2) Method for culturing chorioallantoic membrane or yolk sac The chorioallantoic membrane-derived cell or yolk sac-derived cell obtained in (1) contains 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (PS) solution In addition to the prepared DMEM (hereinafter referred to as FBS / PS-containing DMEM), the cells were seeded in a cell culture dish (diameter 10 cm) at a concentration of 4 × 10 6 cells / dish, and the amount was 2 to 3 at 37 ° C. and 5% CO 2 environment. Cultured for 4 days.

(3)培養上清の回収方法
 (2)で示した培養方法によって調製した漿尿膜培養液又は卵黄嚢培養液を0.22μmのフィルターを用いてろ過し、得られた濾液を動物細胞増殖促進剤として動物細胞培養に用いた。なお、調製した培養上清を保存する場合には、-20℃で凍結して保存した。
(3) Method for recovering culture supernatant The chorioallantoic membrane culture solution or yolk sac culture solution prepared by the culture method shown in (2) was filtered using a 0.22 μm filter, and the obtained filtrate was used as an animal cell growth medium. Used as a promoter in animal cell culture. When the prepared culture supernatant was stored, it was frozen at -20 ° C and stored.

(4)動物細胞培養
(4-1)各組織からの細胞の単離方法
 培養に用いるニワトリ細胞は、以下の方法によって単離した。
(4) Animal cell culture (4-1) Method for isolating cells from each tissue Chicken cells used for culture were isolated by the following method.

 まず、ニワトリの有精卵を37℃でインキュベートし、14日後に卵殻を割って、ニワトリ胚を取り出した。このニワトリ14日胚から胃、骨格筋、心臓、胆嚢、腸、脳、ファブリキウス嚢及び骨を単離し、それぞれHBSS溶液に浸漬した。その後、(1)と同様の方法で各組織由来の細胞を単離した。 First, fertilized chicken eggs were incubated at 37 ° C, and 14 days later, the eggshells were broken and the chicken embryos were taken out. A stomach, skeletal muscle, heart, gall bladder, intestine, brain, bursa of Fabricius and bone were isolated from the embryonic day 14 chicken, and each was immersed in an HBSS solution. Then, cells derived from each tissue were isolated by the same method as in (1).

(4-2)各組織からの細胞の培養方法
 各組織由来の細胞は、FBS・PS含有DMEMに(3)で調製した漿尿膜培養上清又は卵黄嚢培養上清を等量加えた培養用培地を用いて、(2)と同様の方法で培養を行った。なお、対照として、漿尿膜培養上清又は卵黄嚢培養上清を添加せずにFBS・PS含有DMEMのみの培地を用いた以外は同じ条件で培養した細胞を用いた。
(4-2) Method for culturing cells from each tissue Cells derived from each tissue are cultured by adding an equal amount of the chorioallantoic membrane culture supernatant or the yolk sac culture supernatant prepared in (3) to FBS / PS-containing DMEM. Culture was performed in the same manner as in (2) using the culture medium. As a control, cells cultured under the same conditions were used, except that the chorioallantoic membrane culture supernatant or yolk sac culture supernatant was not added and the medium containing only FBS / PS-containing DMEM was used.

(4-3)各培養における、細胞数の計測方法
 (4-2)の結果を、肝臓、膵臓、輸卵管、胃、筋肉、心臓、腸、脳、ファブリキウス嚢及び骨由来の細胞について、定量的に評価した。ここで、各組織由来の細胞数は、以下の方法によって計測した。
(4-3) Counting the number of cells in each culture The results of (4-2) were quantitatively analyzed for cells derived from liver, pancreas, oviduct, stomach, muscle, heart, intestine, brain, bursa of Fabricius and bone. Evaluated to. Here, the number of cells derived from each tissue was measured by the following method.

 まず、各組織由来の細胞の培養液をディッシュから除去し、PBSを加えて細胞をそれぞれ洗浄した。PBSを取り除いた後、トリプシン-EDTA溶液を加え、37℃で1~2分間インキュベートして細胞を剥離させた後、FBS・PS含有DMEMを加えて反応を停止させた。剥離した細胞を含む溶液をすべて回収し、これを遠心分離することで細胞を得た。さらに、この細胞にFBS・PSを加えて懸濁し、この細胞懸濁液20μLとトリパンブルー溶液20μLとを混合した。この細胞懸濁液中で、トリパンブルーで染色されていない生きた細胞の数を、顕微鏡下で、血球計算盤を用いて計測した。 First, the culture solution of cells derived from each tissue was removed from the dish, and PBS was added to wash the cells. After removing the PBS, a trypsin-EDTA solution was added and the cells were detached by incubating at 37 ° C. for 1 to 2 minutes, and then FBS / PS-containing DMEM was added to stop the reaction. All the solution containing the detached cells was collected and centrifuged to obtain cells. Further, FBS.PS was added to the cells to suspend the cells, and 20 μL of the cell suspension was mixed with 20 μL of trypan blue solution. The number of live cells not stained with trypan blue in this cell suspension was counted under a microscope using a hemocytometer.

(4-4)結果
 まず、漿尿膜培養上清を添加した培地で約3~5日間培養した時の細胞を位相差顕微鏡で観察した。図2にその細胞の写真を示すが、どの細胞を培養した場合も、(3)で調製した漿尿膜培養上清を添加した場合のほうが、漿尿膜培養上清を添加しない場合より細胞数が多かった。これは、添加した漿尿膜培養上清によって細胞の増殖が促進されたことを示している。
(4-4) Results First, cells were observed with a phase-contrast microscope when cultured in a medium supplemented with chorioallantoic membrane culture supernatant for about 3 to 5 days. Fig. 2 shows a photograph of the cells. In any cell culture, the cells with the chorioallantoic membrane culture supernatant prepared in (3) were added more than with the cells without the chorioallantoic membrane culture supernatant. There were many. This indicates that the growth of cells was promoted by the added chorioallantoic membrane culture supernatant.

 この結果を定量的に示すため、肝臓、膵臓、輸卵管由来の細胞に対して漿尿膜培養上清を用い、3個のシャーレで実験した場合の細胞数の平均と標準誤差を図3に示したが、肝臓、膵臓、輸卵管由来の細胞のいずれの場合も、漿尿膜培養上清を添加したほうが、漿尿膜培養上清を添加しない場合に比べて約2.5~4倍に細胞が増殖していた。 In order to quantitatively show these results, FIG. 3 shows the average number of cells and the standard error in the case of using the chorioallantoic membrane culture supernatant for cells derived from the liver, pancreas, and oviduct in three petri dishes. However, in all cases of liver, pancreas, and oviduct-derived cells, the addition of chorioallantoic membrane culture supernatant resulted in approximately 2.5 to 4 times more cells than the case without addition of chorioallantoic membrane culture supernatant. Was growing.

 次に、卵黄嚢培養上清を添加した培地を用いて、胃、筋肉、心臓、肝臓、腸、脳、ファブリキウス嚢及び骨由来の細胞に対する増殖促進効果についても同様に調べたところ(n=2)、図4に示したように、いずれの場合も卵黄嚢培養上清を添加した場合のほうが、漿尿膜培養上清を添加しない場合より細胞数が多かった。これは、添加した卵黄嚢培養上清によって細胞の増殖が促進されたことを示している。 Next, using a medium supplemented with the yolk sac culture supernatant, the growth promoting effect on cells of the stomach, muscle, heart, liver, intestine, brain, bursa of Fabricius and bone was also examined (n = 2). ), As shown in FIG. 4, in each case, the number of cells in the case of adding the yolk sac culture supernatant was higher than that in the case of not adding the chorioallantoic membrane culture supernatant. This indicates that cell culture was promoted by the added yolk sac culture supernatant.

 本発明によって、新規な動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置を提供することができるようになった。 The present invention has made it possible to provide a novel animal cell growth promoter, an animal cell culture medium, and an animal cell culture device.

Claims (8)

 鳥または爬虫類の有精卵由来の胚膜の培養上清を有効成分として含有する動物細胞培養増殖促進剤 Animal cell culture growth promoter containing, as an active ingredient, the culture supernatant of embryonic membrane derived from fertilized eggs of birds or reptiles  前記胚膜が羊膜、漿尿膜及び卵黄嚢からなる群から選択される少なくとも1種である、請求項1に記載の動物細胞増殖促進剤。 The animal cell proliferation promoter according to claim 1, wherein the embryonic membrane is at least one selected from the group consisting of amniotic membrane, chorioallantoic membrane and yolk sac.  前記卵が鶏卵である、請求項1又は2に記載の動物細胞増殖促進剤。 The animal cell growth promoter according to claim 1 or 2, wherein the egg is a chicken egg.  筋肉系細胞、内臓系細胞、または神経系細胞に対する細胞増殖剤である、請求項1~3のいずれか1項に記載の動物細胞増殖促進剤。 The animal cell growth promoter according to any one of claims 1 to 3, which is a cell growth agent for muscle cells, visceral cells, or nervous cells.  肝臓細胞、膵臓細胞、輸卵管細胞に対する細胞増殖剤である、請求項1~3のいずれか1項に記載の動物細胞増殖促進剤。 The animal cell growth promoter according to any one of claims 1 to 3, which is a cell growth agent for liver cells, pancreatic cells, and oviduct cells.  請求項1~5のいずれか1項に記載の細胞増殖促進剤を含有する細胞培養用培地。 A cell culture medium containing the cell growth promoter according to any one of claims 1 to 5.  鳥類または爬虫類の卵の胚膜由来の細胞を培養する第1の培養槽と、
 増殖を目的とする動物細胞を培養する第2の培養槽と、
 第1の培養槽から第2の培養槽へ培地を流す第1の流路と、
 第2の培養槽から第1の培養槽へ培地を流す第2の流路と、
 第1の培養槽、第1の流路、第2の培養槽、第2の流路の順に細胞培養用培地を還流させ、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、第1の流路及び第2の流路における前記細胞培養用培地の流れを制御する培地流量制御部と、を備える動物細胞培養装置。
A first culture vessel for culturing cells derived from the embryonic membrane of a bird or reptile egg;
A second culture vessel for culturing animal cells for the purpose of proliferation,
A first flow path for flowing a medium from the first culture tank to the second culture tank;
A second flow path for flowing the medium from the second culture tank to the first culture tank;
The cell culture medium is refluxed in the order of the first culture tank, the first flow path, the second culture tank, and the second flow path, and the first culture tank is returned according to the state of the animal cells and / or the cell culture medium. And a medium flow rate control unit that controls the flow of the cell culture medium in the second flow channel and the second flow channel.
 前記還流する前記細胞培養用培地に新鮮な細胞培養用培地を導入するための培地導入路と、
 前記還流する前記細胞培養用培地から培養後の細胞培養用培地を除去するための培地除去路と、をさらに有し、
 前記培地流量制御部は、前記動物細胞及び/又は前記細胞培養用培地の状態に従って、前記培地導入路からの前記新鮮な細胞培養用培地の導入及び前記培地除去路からの前記培養後の細胞培養用培地の除去を制御する、請求項7に記載の動物細胞培養装置。
A medium introduction path for introducing a fresh cell culture medium into the refluxing cell culture medium,
Further comprising a medium removal path for removing the cell culture medium after culturing from the cell culture medium to be refluxed,
The medium flow rate control unit introduces the fresh cell culture medium from the medium introduction path and cell culture after the culture from the medium removal path according to the state of the animal cells and / or the cell culture medium. The animal cell culture device according to claim 7, which controls the removal of the culture medium.
PCT/JP2019/043713 2018-11-08 2019-11-07 Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus Ceased WO2020096004A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US17/292,131 US20210395678A1 (en) 2018-11-08 2019-11-07 Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus
KR1020247023865A KR20240116562A (en) 2018-11-08 2019-11-07 Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus
SG11202104775SA SG11202104775SA (en) 2018-11-08 2019-11-07 Animal Cell Growth Promoter, Medium For Culturing Animal Cells, And Device For Culturing Animal Cells
EP19883197.6A EP3878941A4 (en) 2019-11-07 Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus
CN201980074375.3A CN113015789A (en) 2018-11-08 2019-11-07 Animal cell growth promoter, medium for animal cell culture, and animal cell culture device
CN202510480890.9A CN120290455A (en) 2018-11-08 2019-11-07 Animal cell proliferation promoter, culture medium for animal cell culture, and animal cell culture device
JP2020555593A JP7488571B2 (en) 2018-11-08 2019-11-07 Animal cell proliferation promoter, animal cell culture medium and animal cell culture device
KR1020217016436A KR102686837B1 (en) 2018-11-08 2019-11-07 Animal cell proliferation promoter, medium for animal cell culture, and animal cell culture device
JP2023207262A JP7628338B2 (en) 2018-11-08 2023-12-07 Animal cell proliferation promoter, animal cell culture medium and animal cell culture device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018-210910 2018-11-08
JP2018210910 2018-11-08

Publications (1)

Publication Number Publication Date
WO2020096004A1 true WO2020096004A1 (en) 2020-05-14

Family

ID=70612097

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/043713 Ceased WO2020096004A1 (en) 2018-11-08 2019-11-07 Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus

Country Status (6)

Country Link
US (1) US20210395678A1 (en)
JP (2) JP7488571B2 (en)
KR (2) KR102686837B1 (en)
CN (2) CN120290455A (en)
SG (1) SG11202104775SA (en)
WO (1) WO2020096004A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022155379A (en) * 2021-03-30 2022-10-13 インテグリカルチャー株式会社 Method for decomposing embryonic membrane
WO2023132371A1 (en) * 2022-01-07 2023-07-13 インテグリカルチャー株式会社 Method for culturing liver-derived cells and culture system including liver-derived cells
JP7323966B1 (en) 2023-03-10 2023-08-09 ダイバースファーム株式会社 Method for producing culture composition
WO2023149408A1 (en) * 2022-02-02 2023-08-10 株式会社ユーグレナ Cosmetic composition, cosmetic composition for epidermal keratinocyte proliferation, epidermal keratinocyte proliferation agent, antioxidant, cosmetic composition for dermal papilla cell proliferation, dermal papilla cell proliferation agent, hair restorer, loricrin gene expression promoter, heme oxygenase-1 gene expression promoter, and cornified envelope formation promoter
WO2023229039A1 (en) * 2022-05-27 2023-11-30 学校法人東京女子医科大学 Cell culture method
WO2024024857A1 (en) * 2022-07-27 2024-02-01 インテグリカルチャー株式会社 Cell state estimation system
WO2024147330A1 (en) * 2023-01-06 2024-07-11 インテグリカルチャー株式会社 Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells
WO2025009590A1 (en) * 2023-07-06 2025-01-09 インテグリカルチャー株式会社 Method for culturing tissue-derived cells, and culture device containing tissue-derived cells

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102827999B1 (en) * 2022-02-11 2025-06-30 중앙대학교 산학협력단 Composition for promoting cell growth derived from embryonated eggs for producing cultured meat and method for preparing the same

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61209585A (en) * 1985-03-14 1986-09-17 Q P Corp Medium for cell culture
JPS62166883A (en) * 1986-01-20 1987-07-23 Q P Corp Culture medium for animal cell
JPH05301893A (en) 1991-02-14 1993-11-16 Takeda Chem Ind Ltd Glia-activating factor and its production
JPH07188292A (en) 1994-08-19 1995-07-25 Snow Brand Milk Prod Co Ltd Glycoprotein derived from human, physiologically active factor composed of the same glycoprotein and pharmaceutical preparation containing the same active ingredient
JP2006280234A (en) * 2005-03-31 2006-10-19 Hitachi Medical Corp Cell proliferation or differentiation method
JP2011182736A (en) 2010-03-10 2011-09-22 Fuji Oil Co Ltd Medium for culturing animal cell
JP2013247927A (en) 2012-06-01 2013-12-12 Univ Of Fukui Rice bran-originated cell proliferation promoter
WO2017191691A1 (en) * 2016-05-02 2017-11-09 インテグリカルチャー株式会社 Growth induction system, growth induction control apparatus, growth induction control method, and growth induction control program

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508762A (en) * 1991-07-15 1994-10-06 エディソン アニマル バイオテクノロジー センター,オハイオ ユニバーシティー yolk sac stem cells
KR100834731B1 (en) * 2003-01-07 2008-06-13 주식회사 바이오랜드 Use of amnion as a substrate or basement membrane for cell culture and preparation method as cell therapeutic agent using same
US20070178586A1 (en) 2005-11-09 2007-08-02 The Ohio State University Research Foundation Methods and apparatuses for growing cells
JP2008061127A (en) * 2006-09-01 2008-03-13 Sharp Corp Coaxial cable connection board, converter and high frequency equipment
CA2743566C (en) * 2008-11-19 2021-11-09 Anthrogenesis Corporation Amnion derived adherent cells
CN101497874B (en) * 2009-03-04 2012-05-23 中山大学中山眼科中心 Method for promoting somatic cell proliferation
CN201626960U (en) * 2010-02-01 2010-11-10 中国农业科学院北京畜牧兽医研究所 Perfusion Apparatus for Stem Cell Culture
CN102329771A (en) * 2011-10-12 2012-01-25 佛山科学技术学院 Method and special culture medium for subculturing chicken embryonic stem cells for long time
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells
CN104099294A (en) * 2013-04-03 2014-10-15 北京京蒙高科干细胞技术有限公司 Medium based on stem cell-excreted factor and its preparation method and use method
CN103289952A (en) * 2013-06-04 2013-09-11 厦门大学 Cell or tissue culture method
CN104818244B (en) * 2015-05-21 2017-12-29 天晴干细胞股份有限公司 A kind of amniotic epithelial cells separation, the method for culture
US20190029235A1 (en) * 2015-11-05 2019-01-31 Baylor College Of Medicine Efficient, scalable patient-derived xenograft system based on a chick chorioallantoic membrane (cam) in vivo model
CN105316309A (en) * 2015-12-04 2016-02-10 广州赛莱拉干细胞科技股份有限公司 Digestive enzyme composition and preparation method of fibroblasts and feeder layer cells
JP6111510B1 (en) * 2016-05-02 2017-04-12 インテグリカルチャー株式会社 Growth induction system, growth induction control device, growth induction control method, and growth induction control program
US11292999B2 (en) * 2016-08-30 2022-04-05 Finesse Solutions, Inc. Bioreactor with multiple coupled vessels
CN107058217A (en) * 2017-01-22 2017-08-18 广州赛莱拉干细胞科技股份有限公司 The proliferated culture medium and Multiplying culture method of a kind of cartilage cell
KR102121042B1 (en) * 2017-12-06 2020-06-09 이정복 Medium composition for cell proliferation, skin regeneration and wrinkle improvement comprising conditioned medium of pluripotent stem cells, neural stem cells and embryonic fibroblasts isolated from an egg of a bird
CN108373995B (en) * 2018-02-14 2020-11-17 浙江生创精准医疗科技有限公司 Stem cell conditioned medium, preparation method and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61209585A (en) * 1985-03-14 1986-09-17 Q P Corp Medium for cell culture
JPS62166883A (en) * 1986-01-20 1987-07-23 Q P Corp Culture medium for animal cell
JPH05301893A (en) 1991-02-14 1993-11-16 Takeda Chem Ind Ltd Glia-activating factor and its production
JPH07188292A (en) 1994-08-19 1995-07-25 Snow Brand Milk Prod Co Ltd Glycoprotein derived from human, physiologically active factor composed of the same glycoprotein and pharmaceutical preparation containing the same active ingredient
JP2006280234A (en) * 2005-03-31 2006-10-19 Hitachi Medical Corp Cell proliferation or differentiation method
JP2011182736A (en) 2010-03-10 2011-09-22 Fuji Oil Co Ltd Medium for culturing animal cell
JP2013247927A (en) 2012-06-01 2013-12-12 Univ Of Fukui Rice bran-originated cell proliferation promoter
WO2017191691A1 (en) * 2016-05-02 2017-11-09 インテグリカルチャー株式会社 Growth induction system, growth induction control apparatus, growth induction control method, and growth induction control program

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EIJI ICHISHIMA, KAGAKU TO SEIBUTSU, vol. 13, no. 8, 1975, pages 489 - 497

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022155379A (en) * 2021-03-30 2022-10-13 インテグリカルチャー株式会社 Method for decomposing embryonic membrane
JP7785316B2 (en) 2021-03-30 2025-12-15 インテグリカルチャー株式会社 How to Break Down Embryonic Membranes
WO2023132371A1 (en) * 2022-01-07 2023-07-13 インテグリカルチャー株式会社 Method for culturing liver-derived cells and culture system including liver-derived cells
WO2023149408A1 (en) * 2022-02-02 2023-08-10 株式会社ユーグレナ Cosmetic composition, cosmetic composition for epidermal keratinocyte proliferation, epidermal keratinocyte proliferation agent, antioxidant, cosmetic composition for dermal papilla cell proliferation, dermal papilla cell proliferation agent, hair restorer, loricrin gene expression promoter, heme oxygenase-1 gene expression promoter, and cornified envelope formation promoter
WO2023229039A1 (en) * 2022-05-27 2023-11-30 学校法人東京女子医科大学 Cell culture method
WO2024024857A1 (en) * 2022-07-27 2024-02-01 インテグリカルチャー株式会社 Cell state estimation system
WO2024147330A1 (en) * 2023-01-06 2024-07-11 インテグリカルチャー株式会社 Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells
JP7323966B1 (en) 2023-03-10 2023-08-09 ダイバースファーム株式会社 Method for producing culture composition
JP2024128733A (en) * 2023-03-10 2024-09-24 ダイバースファーム株式会社 Method for Producing a Culture Composition
WO2025009590A1 (en) * 2023-07-06 2025-01-09 インテグリカルチャー株式会社 Method for culturing tissue-derived cells, and culture device containing tissue-derived cells

Also Published As

Publication number Publication date
KR102686837B1 (en) 2024-07-22
JP2024028914A (en) 2024-03-05
SG11202104775SA (en) 2021-06-29
JPWO2020096004A1 (en) 2021-09-24
CN120290455A (en) 2025-07-11
EP3878941A1 (en) 2021-09-15
US20210395678A1 (en) 2021-12-23
KR20240116562A (en) 2024-07-29
KR20210091195A (en) 2021-07-21
CN113015789A (en) 2021-06-22
JP7628338B2 (en) 2025-02-10
JP7488571B2 (en) 2024-05-22

Similar Documents

Publication Publication Date Title
JP7628338B2 (en) Animal cell proliferation promoter, animal cell culture medium and animal cell culture device
CN104350145B (en) Method for culturing bovine and porcine spermatogonial stem cells without feeder cells
Moase et al. Delayed neural crest cell emigration from Sp and Spd mouse neural tube explants
US20090104694A1 (en) Isolation and transplantation of retinal stem cells
RU2620947C2 (en) Biosynthetic systems of proximal tubule and methods of their use
JP2023504217A (en) Methods and uses thereof for enhancing cell growth with species-specific or genus-specific proteins
EP3658666A1 (en) Establishing topographic organization in three-dimensional tissue culture
Kumar et al. Long-term primary culture of neurons taken from chick embryo brain: A model to study neural cell biology, synaptogenesis and its dynamic properties
JP4343946B2 (en) A method for improving the germline transfer efficiency of avian primordial germ cells
JP4267689B2 (en) Method for culturing avian cell and cell line obtained by the culturing method
CN104755610A (en) Adipose tissue cells
JPWO1996006160A1 (en) Method for culturing avian cells and cell lines obtained by said culture method
JP4376901B2 (en) Method for producing avian chimera using spermatogonia and avian chimera
CN101423819A (en) Method for culturing chicken embryonic stem cells and special nutrient fluid thereof
HK40046610A (en) Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus
KR20240130799A (en) Method for culturing liver-derived cells and culture system containing liver-derived cells
CN105073978B (en) A method for inducing customized subpluripotent stem cells by using extracts of plant stem cells or plant dedifferentiated stem cells and subpluripotent stem cells prepared by using the method
CN103571793A (en) Method of regulating and controlling retinal progenitor cell generated by inducing
Sritabtim et al. First study on repeatable culture of primordial germ cells from various embryonic regions with giant feeder cells in Japanese quail (Coturnix japonica)
CN118581031B (en) Goose kidney organoid and culture method and application thereof
CN113801943B (en) Regulatory effect of miR-450b-3p on adipocyte polyester and its application
Hanssen et al. Reverse Engineering of Feedforward Cortical-Hippocampal Neural Networks Relevant for Preclinical Disease Modelling
WO2025009590A1 (en) Method for culturing tissue-derived cells, and culture device containing tissue-derived cells
Wiatrak Establishment and Characterization of Organoids from Mammary Tissue of Lactating Dairy Cows
WO2024147330A1 (en) Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19883197

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2020555593

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20217016436

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2019883197

Country of ref document: EP

Effective date: 20210608